Marken announced that it has completed all commissioning work for its new operational hub in Feltham, UK. The new location at 648 River Gardens in Feltham is within 4 miles (6 KM) of Heathrow Airport and part of the North Feltham Trading Estate Industrial Center.
The 18.5k sq ft facility is completely occupied by Marken operational personnel and will be one of the company’s flagship facilities joining an expanding network. The facility is equipped with space for product staging, re-icing, automatic scanning, quarantined goods, secure storage for dangerous goods, import and export operations and IT support. It will also have ample office space for the London branch operations which also has responsibility for all clients operating within the UK and Ireland.
“This new facility is in direct response to recent expansion requirements in the UK to support our growing client base”, said CEO, Wes Wheeler. “We have designed this facility to accommodate all of the needs of the life science industry including inbound shipments of clinical samples and outbound shipments of drug product, active pharmaceutical ingredients and patient kits. We have allowed ample room for growth and for expanded services. We are very excited to be upgrading our facilities in the UK.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Truqap Combination Shines in Phase III Trial for Prostate Cancer
November 26th 2024Data from the CAPItello-281 trial show Truqap alongside abiraterone and androgen deprivation therapy achieved a statistically significant and clinically meaningful improvement in radiographic progression-free survival.
Empowering Sites and Patients: The Impact of Personalized Support in Clinical Trials
November 26th 2024To meet the growing demands of clinical research, sponsors must prioritize comprehensive support models, such as clinical site ambassadors and patient journey coordinators, who can address operational challenges and improve site relationships, patient satisfaction, and overall trial efficiency.